| Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups N Bolli, G Biancon, M Moarii, S Gimondi, Y Li, C de Philippis, F Maura, ... Leukemia 32 (12), 2604-2616, 2018 | 186 | 2018 |
| m6A modification prevents formation of endogenous double-stranded RNAs and deleterious innate immune responses during hematopoietic development Y Gao, R Vasic, Y Song, R Teng, C Liu, R Gbyli, G Biancon, R Nelakanti, ... Immunity 52 (6), 1007-1021. e8, 2020 | 123 | 2020 |
| Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma B Ziccheddu, G Biancon, F Bagnoli, C De Philippis, F Maura, EH Rustad, ... Blood advances 4 (5), 830-844, 2020 | 55 | 2020 |
| Noninvasive molecular monitoring in multiple myeloma patients using cell-free tumor DNA: a pilot study G Biancon, S Gimondi, A Vendramin, C Carniti, P Corradini The Journal of Molecular Diagnostics 20 (6), 859-870, 2018 | 54 | 2018 |
| Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation S Gimondi, M Dugo, A Vendramin, A Bermema, G Biancon, A Cavané, ... Experimental Hematology 44 (7), 624-634. e1, 2016 | 34 | 2016 |
| Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis HH Öz, EC Cheng, C Di Pietro, T Tebaldi, G Biancon, C Zeiss, PX Zhang, ... Cell reports 41 (11), 2022 | 29 | 2022 |
| From clonal hematopoiesis to myeloid leukemia and what happens in between: will improved understanding lead to new therapeutic and preventive opportunities? JP Bewersdorf, A Ardasheva, NA Podoltsev, A Singh, G Biancon, ... Blood reviews 37, 100587, 2019 | 29 | 2019 |
| Precision analysis of mutant U2AF1 activity reveals deployment of stress granules in myeloid malignancies G Biancon, P Joshi, JT Zimmer, T Hunck, Y Gao, MD Lessard, ... Molecular cell 82 (6), 1107-1122. e7, 2022 | 28 | 2022 |
| Combined liver–cytokine humanization comes to the rescue of circulating human red blood cells Y Song, L Shan, R Gbyli, W Liu, T Strowig, A Patel, X Fu, X Wang, ML Xu, ... Science 371 (6533), 1019-1025, 2021 | 23 | 2021 |
| In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2 R Gbyli, Y Song, W Liu, Y Gao, G Biancon, NS Chandhok, X Wang, X Fu, ... Leukemia 36 (5), 1313-1323, 2022 | 11 | 2022 |
| Pre-mRNA splicing factor U2AF2 recognizes distinct conformations of nucleotide variants at the center of the pre-mRNA splice site signal E Glasser, D Maji, G Biancon, AMK Puthenpeedikakkal, CE Cavender, ... Nucleic Acids Research 50 (9), 5299-5312, 2022 | 10 | 2022 |
| Tyrosine kinase inhibition to improve anthracycline-based chemotherapy efficacy in T-cell lymphoma M Magni, G Biancon, S Rizzitano, A Cavanè, C Paolizzi, M Dugo, ... British journal of cancer 121 (7), 567-577, 2019 | 7 | 2019 |
| Widespread association of the Argonaute protein AGO2 with meiotic chromatin suggests a distinct nuclear function in mammalian male reproduction KN Griffin, BW Walters, H Li, H Wang, G Biancon, T Tebaldi, CB Kaya, ... Genome Research 32 (9), 1655-1668, 2022 | 6 | 2022 |
| Mission, organization, and future direction of the serological sciences network for COVID-19 (SeroNet) epidemiologic cohort studies JC Figueiredo, FR Hirsch, LH Kushi, WN Nembhard, JM Crawford, ... Open Forum Infectious Diseases 9 (6), ofac171, 2022 | 6 | 2022 |
| ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control Y Gao, JT Zimmer, R Vasic, C Liu, R Gbyli, SJ Zheng, A Patel, W Liu, Z Qi, ... Cell Reports 42 (10), 2023 | 4 | 2023 |
| Microfluidic Immuno‐Serolomic Assay Reveals Systems Level Association with COVID‐19 Pathology and Vaccine Protection D Kim, G Biancon, Z Bai, J VanOudenhove, Y Liu, S Kothari, L Gowda, ... Small Methods 7 (10), 2300594, 2023 | 3 | 2023 |
| Comprehensive clinicopathologic and molecular analysis of mast cell leukemia with associated hematologic neoplasm: A report and in-depth study of 5 cases P Li, G Biancon, T Patel, Z Pan, S Kothari, S Halene, T Prebet, ML Xu Frontiers in Oncology 11, 730503, 2021 | 3 | 2021 |
| Multi-omics profiling of U2AF1 mutants dissects pathogenic mechanisms affecting RNA granules in myeloid malignancies G Biancon, P Joshi, JT Zimmer, T Hunck, Y Gao, MD Lessard, ... bioRxiv, 2021.04. 22.441020, 2021 | 3 | 2021 |
| The genomic and transcriptomic landscape of double-refractory multiple myeloma B Ziccheddu, G Biancon, C De Philippis, F Bagnoli, F Maura, M Dugo, ... Blood 134, 3056, 2019 | 3 | 2019 |
| PARP Inhibitors Are Effective in IDH1/2 Mutant MDS and AML Resistant to Targeted IDH Inhibitors R Gbyli, Y Song, W Liu, Y Gao, NS Chandhok, X Fu, X Wang, A Patel, ... Blood 134, 4222, 2019 | 3 | 2019 |
